RPL26A Antibody

What is RPL26 and what cellular functions does it perform?

RPL26 (ribosomal protein L26) functions as a component of the large ribosomal subunit (60S), playing a critical role in the ribonucleoprotein complex responsible for cellular protein synthesis . Beyond its structural role in ribosomes, RPL26 has been identified as a significant regulator of p53 mRNA translation following cellular stress, particularly DNA damage . The protein has a calculated molecular weight of 17 kDa but is typically observed at 17-22 kDa in experimental settings . RPL26 is widely expressed across human cell types, with antibody reactivity confirmed in various human cancer cell lines including K-562, HeLa, HepG2, and Jurkat cells .

What applications can RPL26 antibodies be used for in research?

RPL26 antibodies have been validated for multiple experimental applications:

The successful application of RPL26 antibodies has been documented across multiple research publications, particularly in studies examining p53 regulation, ribosomal biology, and stress response mechanisms . For optimal results, antibody titration is recommended in each specific testing system to determine ideal working conditions .

How should RPL26 antibodies be stored and handled to maintain reactivity?

RPL26 antibodies are typically supplied in PBS buffer containing 0.02% sodium azide and 50% glycerol at pH 7.3 . For long-term stability, storage at -20°C is recommended, where the antibody remains stable for approximately one year after shipment . Unlike some antibodies that require aliquoting, RPL26 antibodies in the provided storage buffer can generally be maintained at -20°C without dividing into smaller volumes . Certain preparations may contain 0.1% BSA as a stabilizer, particularly in smaller volume formats (20μl) . When handling the antibody for experimental procedures, avoid repeated freeze-thaw cycles and maintain cold chain protocols during all manipulation steps.

How does RPL26 interact with nucleolin to regulate p53 translation?

The regulation of p53 translation involves a complex interplay between RPL26 and nucleolin (NCL), centered around a double-stranded RNA structure formed by complementary sequences in the 5' and 3'-UTRs of p53 mRNA . Under normal conditions, nucleolin suppresses p53 translation through:

• Binding to both the 5' and 3'-UTRs of p53 mRNA

• Forming a homodimer that stabilizes the double-stranded RNA structure

• Preventing ribosomal engagement with the mRNA

Following cellular stress, particularly DNA damage, this suppression is relieved when:

• RPL26 is recruited to the same UTR interaction region

• RPL26 disrupts nucleolin dimerization

• This disruption serves as a molecular switch from translational repression to activation

Experimental evidence shows that mutations in the NCL-interacting region of RPL26 reduce both their interaction and attenuate RPL26 binding to human p53 mRNA, consequently diminishing p53 induction . This mechanism represents a critical regulatory node in the cellular stress response pathway, where the competition between nucleolin and RPL26 determines the translational status of p53 mRNA .

What approaches can be used to study unassembled versus ribosome-incorporated RPL26?

Distinguishing between unassembled and ribosome-incorporated RPL26 requires specific experimental approaches:

• Sucrose gradient fractionation: This technique separates cellular components based on their sedimentation properties. Unassembled RPL26 is found in the low-molecular-weight fractions, while ribosome-incorporated RPL26 sediments with 60S subunits, 80S ribosomes, and polysomes .

• Subcellular fractionation: This approach can separate nuclear and cytoplasmic pools of RPL26. Unassembled RPL26 is often enriched in the nucleus, particularly in the nucleolus, as visualized by co-localization with nucleolar markers like Nop56-mRFP .

• Ubiquitination analysis: Unassembled RPL26 is preferentially targeted for ubiquitination and subsequent degradation. Using ubiquitin-binding resins (UBA resin) with gradient fractions can identify which population contains ubiquitin conjugates - research shows these are exclusively found in the unassembled fraction .

• Fluorescence microscopy: Tagged RPL26 (e.g., RPL26-GFP) can be used to visualize its localization pattern. Unassembled RPL26 often appears in distinct nuclear foci, particularly in the nucleolus, while assembled RPL26 shows a more diffuse cytoplasmic pattern .

When designed properly, these approaches can provide complementary data on the differential regulation and fate of RPL26 depending on its assembly status.

How does the proteasome-mediated degradation of excess RPL26 function?

The degradation of excess unassembled RPL26 involves a sophisticated protein quality control mechanism:

• Selective targeting: Only unassembled forms of RPL26 are targeted for degradation, while ribosome-incorporated molecules remain protected . This selectivity ensures that only functional, assembled ribosomes persist in the cell.

• Ubiquitination: Excess RPL26 undergoes polyubiquitination, which marks it for proteasomal degradation. This modification occurs exclusively on the unassembled fraction, as confirmed by UBA resin binding experiments .

• Proteasome dependency: Inhibition of the proteasome with bortezomib leads to substantial accumulation of unassembled RPL26, confirming the role of the proteasome in this degradation pathway .

• Subcellular localization: Degradation primarily occurs in the nucleus, with the most intense accumulation of RPL26 observed in the nucleolus when degradation is blocked .

• Independence from San1: Unlike many nuclear quality control processes, RPL26 degradation does not depend on the San1 ubiquitin ligase, suggesting involvement of an alternative protein quality control pathway .

This degradation system demonstrates remarkable specificity, as overexpression of RPL26 in the presence of proteasome inhibitors results in massive accumulation of unassembled protein but only minimal increases in ribosome-incorporated RPL26 .

What is the significance of RPL26 UFMylation in ribosome-associated quality control?

RPL26 (also known as uL24) undergoes a post-translational modification called UFMylation, which involves the conjugation of UFM1, a ubiquitin-like protein, specifically to ribosomes bound to the endoplasmic reticulum (ER) . This modification plays a crucial role in ribosome-associated quality control, particularly for proteins undergoing cotranslational translocation into the ER.

Research indicates that UFMylation of RPL26 facilitates proteasome-mediated degradation of arrest polypeptides (APs) . These APs are generated when ribosomes stall during the cotranslational translocation of secretory proteins into the ER, leading to ribosome splitting . The UFMylation process appears to be an essential component of the cellular machinery that resolves these stalled translation events, preventing the accumulation of potentially toxic incomplete polypeptides.

This finding connects RPL26 to broader cellular quality control mechanisms beyond its structural role in the ribosome, highlighting how post-translational modifications of ribosomal proteins can confer specialized regulatory functions in protein synthesis fidelity.

How can I optimize RPL26 antibody for detecting stress-induced translational changes?

To effectively study stress-induced translational changes mediated by RPL26, consider these optimization approaches:

• Stress induction protocols: DNA damage agents such as UV radiation or chemical agents (e.g., doxorubicin) can be used to induce p53-dependent stress responses where RPL26 plays a regulatory role .

• Timing considerations: RPL26's role in p53 mRNA translation is dynamic and time-dependent following stress. Design time-course experiments (typically 2-24 hours post-stress) to capture the relevant translational changes .

• Polysome profiling: Combine sucrose gradient fractionation with RPL26 antibody detection to monitor RPL26 recruitment to actively translating ribosomes following stress .

• Co-immunoprecipitation: Use RPL26 antibodies for RNA immunoprecipitation (RIP) to detect increased association with p53 mRNA after stress induction .

• Dual detection: Simultaneously monitor RPL26 and nucleolin localization and binding to determine the competitive interplay between these proteins on p53 mRNA .

• Controls: Include both stressed and unstressed conditions, as well as cell lines with RPL26 knockdown or overexpression to establish baselines and maximum response ranges .

• Antibody dilution: For stress-response studies, consider using RPL26 antibodies at the more concentrated end of the recommended dilution range (e.g., 1:500 for Western blot) to ensure detection of potentially subtle changes in protein-RNA interactions .

What are the considerations for using RPL26 antibodies in cancer research?

RPL26 has emerged as a significant factor in cancer biology due to its regulatory role in p53 translation and cellular stress responses. When utilizing RPL26 antibodies in cancer research, consider:

• Differential expression: RPL26 antibodies have been successfully applied to detect the protein in various cancer cell lines (K-562, HeLa, HepG2, Jurkat) and cancer tissues (ovarian carcinoma, skin basal cell carcinoma), making them valuable tools for studying potential variations in RPL26 expression across cancer types .

• p53 status consideration: Since RPL26 regulates p53 translation, the p53 status of cell lines or tissues (wild-type, mutant, or null) should be considered when interpreting RPL26 antibody results, as its functional significance may vary accordingly .

• Application-specific optimization:

  • For IHC in cancer tissues, dilutions of 1:250 to 1:500 have been validated, with detection performed using DAB staining and secondary anti-Rabbit IHC antibodies at 1:100 dilution .

  • For detecting RPL26 in cancer cell lysates via Western blot, a dilution range of 1:500-1:1000 is recommended .

• Functional studies: Beyond detection, RPL26 antibodies can be employed in mechanistic studies examining how alterations in the RPL26-nucleolin axis might contribute to dysregulated p53 responses in cancer cells .

• Subcellular localization: In cancer research, combining RPL26 antibody detection with subcellular fractionation or immunofluorescence can reveal potential alterations in RPL26 localization patterns that might correlate with malignant transformation .

• Correlation with clinical parameters: When applied to patient samples, consider correlating RPL26 detection patterns with clinical parameters to assess potential prognostic or diagnostic value .

What are common challenges in detecting RPL26 and how can they be addressed?

Researchers may encounter several challenges when working with RPL26 antibodies:

• Multiple molecular weight bands: RPL26 has a calculated molecular weight of 17 kDa but is observed at 17-22 kDa range . Additionally, post-translational modifications like ubiquitination can result in higher molecular weight species .

  • Solution: Always include appropriate positive controls with known RPL26 expression (e.g., HeLa cells) to identify the correct band. Consider using gradient gels that provide better resolution in the lower molecular weight range.

• Processing artifacts: Some studies have observed that unassembled RPL26 can undergo processing during experimental procedures, resulting in faster migrating species on SDS-PAGE .

  • Solution: Prepare samples under denaturing conditions and minimize handling time. Compare protein patterns from whole cell lysates prepared under denaturing conditions with those from sucrose gradient fractions.

• Antibody cross-reactivity: Due to the conserved nature of ribosomal proteins, some antibodies may cross-react with related proteins.

  • Solution: Validate specificity using knockdown/knockout controls or peptide competition assays. Select antibodies raised against unique regions of RPL26.

• Low signal in immunofluorescence: Nuclear/nucleolar proteins can sometimes be difficult to detect by immunofluorescence due to epitope masking.

  • Solution: Test different fixation and permeabilization protocols. For RPL26, a dilution range of 1:50-1:500 is recommended for IF/ICC applications, with successful detection reported in HeLa cells .

• Variable expression in different cell types: Expression levels of RPL26 may vary across cell types.

  • Solution: Adjust antibody concentrations accordingly and consider longer exposure times for Western blots when working with low-expressing cell types.

How can I design experiments to study the RPL26-nucleolin interaction in regulating p53 translation?

To effectively investigate the regulatory interaction between RPL26 and nucleolin on p53 translation, consider these experimental approaches:

• Co-immunoprecipitation (Co-IP):

  • Use RPL26 antibodies to pull down protein complexes, then blot for nucleolin and vice versa

  • Include both basal and stress-induced conditions to observe dynamic changes in interaction

  • Consider using crosslinking approaches to capture transient interactions

• RNA immunoprecipitation (RIP):

  • Precipitate RPL26 or nucleolin and assay for associated p53 mRNA

  • Compare binding patterns before and after stress induction

  • Quantify enrichment by qRT-PCR targeting specific regions of p53 mRNA

• Mutational analysis:

  • Generate point mutations in the NCL-interacting region of RPL26

  • Assess how these mutations affect:

    • RPL26-nucleolin protein interaction (by Co-IP)

    • Binding to p53 mRNA (by RIP)

    • p53 induction following stress (by Western blot)

• Competitive binding assays:

  • In vitro binding assays with recombinant proteins and synthesized p53 mRNA UTR fragments

  • Titrate increasing concentrations of one protein while keeping the other constant

  • Map the binding regions using truncated constructs

• Translational reporter assays:

  • Generate luciferase reporters containing p53 5' and 3' UTRs

  • Assess how RPL26 and nucleolin overexpression or depletion affects reporter activity

  • Include stress conditions to observe dynamic regulation

• Structural analysis:

  • Investigate how RPL26 disrupts nucleolin dimerization

  • Consider techniques like FRET to monitor protein-protein interactions in living cells

When interpreting results, remember that nucleolin represses basal p53 translation using both 5' and 3'-UTRs of p53 mRNA, while RPL26 is recruited after stress to enhance translation, with their competitive interaction serving as a molecular switch between translational repression and activation .

What techniques can be used to study RPL26 UFMylation and its role in ribosome quality control?

Investigating RPL26/uL24 UFMylation requires specialized techniques to detect this post-translational modification and understand its functional significance in ribosome-associated quality control:

This research area represents an emerging frontier connecting ribosomal biology with protein quality control mechanisms, particularly highlighting how UFMylation of RPL26 facilitates proteasome-mediated degradation of arrest polypeptides generated during cotranslational protein translocation into the ER .

How can RPL26 antibodies be used in the study of extraribosomal functions of ribosomal proteins?

RPL26 antibodies provide valuable tools for investigating the growing field of extraribosomal functions of ribosomal proteins:

• Stress response pathways:

  • Use RPL26 antibodies to monitor redistribution of the protein during various cellular stresses

  • Combine with subcellular fractionation to track movement between ribosomal and non-ribosomal pools

  • Assess changes in protein-protein interactions using co-immunoprecipitation under different stress conditions

• Translational regulation:

  • Apply RPL26 antibodies in RNA immunoprecipitation to identify novel mRNA targets beyond p53

  • Perform CLIP-seq (Cross-linking immunoprecipitation followed by sequencing) using RPL26 antibodies to map RNA binding sites globally

  • Investigate potential preferential translation of specific mRNAs mediated by RPL26

• Cancer biology applications:

  • Evaluate RPL26 expression patterns in cancer tissues using immunohistochemistry

  • Correlate expression with p53 status and patient outcomes

  • Investigate RPL26 as a potential biomarker for specific cancer types

• Developmental biology:

  • Use RPL26 antibodies to track expression patterns during embryonic development

  • Investigate tissue-specific extraribosomal functions

  • Correlate with key developmental transitions

• Interactome studies:

  • Employ RPL26 antibodies in proximity-dependent biotin identification (BioID) or APEX approaches

  • Identify novel interaction partners in different cellular compartments

  • Compare interactomes between normal and stress conditions

When designing such studies, researchers should consider the specificity of the antibody, appropriate controls (including RPL26 knockdown), and potential cross-reactivity with related ribosomal proteins to ensure accurate interpretation of results .

What emerging research areas involve RPL26 beyond its role in p53 regulation?

Recent research has uncovered several emerging roles for RPL26 beyond its canonical function in ribosome structure and p53 regulation:

• Ribosome-associated quality control mechanisms:

  • RPL26/uL24 UFMylation is essential for the degradation of arrest polypeptides that result from ribosome stalling during cotranslational translocation

  • This connects RPL26 to specialized protein quality control pathways at the endoplasmic reticulum

• Nucleolar stress response:

  • Unassembled RPL26 accumulates in the nucleolus under certain conditions

  • This localization pattern may represent a nucleolar stress response mechanism or function as a sensor for ribosome assembly defects

• Immune regulation:

  • Research indicates RPL26 involvement in transcriptional regulation of CD40 expression via functional SNPs on disease-associated CD40 loci

  • This suggests potential roles in immune response and inflammatory conditions

• Mitochondrial function:

  • Some studies suggest a connection between RPL26 and endosomal lipid signaling that reshapes the endoplasmic reticulum to control mitochondrial functions

  • This points to potential roles in cellular energy metabolism and organelle communication

• Selective mRNA translation:

  • Beyond p53, RPL26 may selectively regulate translation of other specific mRNAs

  • This selectivity could represent a broader regulatory mechanism for controlling gene expression at the translational level